Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic management of pelvic floor dysfunction

I E Nygaard1

  • 1Department of Obstetrics and Gynecology, University of Iowa Hospitals and Clinics, Iowa City, USA.

Obstetrics and Gynecology Clinics of North America
|January 28, 1999
PubMed
Summary

Pharmacologic therapy is key for treating urogynecologic disorders. Future research aims to develop more effective medications with fewer side effects for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity and retropubic surgery for stress incontinence: is there really an increased risk of intraoperative complications?

American journal of obstetrics and gynecology·2006
Same author

Long-term results of the FemSoft urethral insert for the management of female stress urinary incontinence.

International urogynecology journal and pelvic floor dysfunction·2002
Same author

Ureterouterine and vesicoureterovaginal fistulas as a complication of cesarean section.

The Journal of urology·2001
Same author

Resolution of urge symptoms following sling cystourethropexy.

The Journal of urology·2000
Same author

Does prolonged high-impact activity contribute to later urinary incontinence? A retrospective cohort study of female Olympians.

Obstetrics and gynecology·1997
Same author

Anal incontinence after anal sphincter disruption: a 30-year retrospective cohort study.

Obstetrics and gynecology·1997

Area of Science:

  • Urogynecology
  • Pharmacology
  • Medical Therapeutics

Background:

  • Pharmacologic therapy represents a crucial component in managing urogynecologic conditions.
  • The current treatment landscape includes various medications, but ongoing research seeks to refine their application.

Purpose of the Study:

  • To review the role of pharmacologic interventions in urogynecologic disorders.
  • To highlight the ongoing development of novel therapeutic agents with enhanced efficacy and safety profiles.

Main Methods:

  • Literature review of existing pharmacologic treatments for urogynecologic disorders.
  • Analysis of current research trends and future directions in medication development.

Main Results:

  • Pharmacologic agents are integral to the multidisciplinary approach for urogynecologic conditions.
  • Emerging research focuses on developing targeted therapies with improved side effect profiles.

Conclusions:

  • Pharmacologic therapy remains a vital treatment option for urogynecologic disorders.
  • Continued research and development are essential for advancing medication efficacy and patient safety in this field.

Related Experiment Videos